Insider Trading June 4, 2026 07:40 PM

NVIDIA Director Mark Stevens Executes $221 Million Stock Disposition

Executive divestment occurs amid strong market performance and broader AI sector developments

By Nina Shah NVDA

NVIDIA Corporation (NASDAQ: NVDA) director Mark A. Stevens executed a series of indirect stock sales totaling $221.1 million between June 2 and June 4, 2026. The transactions, facilitated through the Third Millennium Trust, involved the disposal of 1 million shares at prices ranging from $217.50 to $222.89. This activity coincides with NVIDIA's stock trading near $218.72, reflecting a 54% annual return. Concurrently, NVIDIA continues to expand its artificial intelligence portfolio through strategic acquisitions and partnerships, while external market commentary highlights both growth opportunities and valuation concerns within the sector.

NVIDIA Director Mark Stevens Executes $221 Million Stock Disposition
NVDA

Key Points

  • NVIDIA director Mark Stevens sold $221.1 million worth of stock through indirect trusts in early June 2026.
  • NVIDIA continues to expand its AI portfolio through significant acquisitions and partnerships, including deals with Kumo AI and Generalist AI.
  • Market sentiment around NVIDIA and the broader AI sector remains mixed, with strong stock performance contrasting with concerns about potential market bubbles.

Mark A. Stevens, serving as a director at NVIDIA Corp (NASDAQ: NVDA), completed a sequence of stock divestments amounting to $221,102,600 in value during early June 2026. The transactions, executed between June 2 and June 4, resulted in the sale of 1 million shares of common stock. The disposal occurred at price points ranging from $217.500 to $222.890 per share. This executive activity takes place while NVIDIA shares are trading at $218.72, a level that reflects a 54% return over the preceding 12 months. Market analysis suggests the stock is trading near its 52-week high of $236.54, with data indicating potential undervaluation relative to current fundamentals.


The initial transaction on June 2 involved the disposal of 500,000 shares at a weighted average price of $222.3774. Individual share prices during this transaction ranged from $222.000 to $222.890. Subsequent activity on June 4 included the sale of 100,000 shares at a weighted average price of $217.655, with execution prices between $217.500 and $217.820. Also on June 4, an additional 400,000 shares were liquidated at a weighted average price of $220.371, with prices ranging from $220.000 to $220.930. All these sales were conducted through indirect holdings managed by the Third Millennium Trust, a vehicle co-trusteeship shared by Stevens and his wife.


Following the sales, a separate transaction on June 4 saw Stevens donate 307,500 shares of common stock without consideration, also sourced from the Third Millennium Trust. Post-transaction, Stevens maintains 6,092,271 shares indirectly through the Third Millennium Trust. His broader portfolio includes 15,017,750 shares held indirectly via the Envy Trust, where he serves as trustee, and 11,543,401 shares held directly. These holdings underscore the significant executive stake remaining in the company despite the recent divestments.


Key Market and Sector Developments

  • Strategic Acquisitions and Partnerships: NVIDIA continues to expand its artificial intelligence capabilities through the acquisition of Kumo AI for over $400 million, targeting predictive enterprise software. Concurrently, Generalist AI, a robotics startup backed by NVIDIA, secured $400 million in funding at a $2 billion valuation, led by Radical Ventures with participation from 8VC, Union Square Ventures, and Bezos Expeditions. Additionally, South Korea's LG Group plans to deploy 10,000 NVIDIA graphics processing units for AI research, including humanoid robotics projects. Navitas Semiconductor also partnered with NVIDIA's MGX™ Ecosystem to advance 800 VDC AI infrastructure.
  • Executive Activity and Market Sentiment: The recent stock sales by director Stevens occur against a backdrop of strong stock performance and active M&A activity in the AI sector. While NVIDIA's stock shows resilience near its 52-week high, external commentary, including concerns from billionaire investor Ray Dalio about potential AI market bubbles, highlights the complex valuation dynamics facing the industry.

Risks and Uncertainties

  • Valuation and Market Volatility: The mention of potential AI market bubbles by investor Ray Dalio introduces uncertainty regarding current stock valuations. Companies in the AI sector face the challenge of balancing aggressive spending to capture market share against the risk of overextension, which could impact investor sentiment and stock performance across the technology sector.
  • Integration and Execution Risks: NVIDIA's aggressive acquisition strategy, including the $400 million purchase of Kumo AI and support for Generalist AI, carries inherent integration risks. The success of these investments depends on the effective incorporation of new technologies and talent into NVIDIA's existing hardware and software portfolio, which could affect future financial performance and competitive positioning.

The intersection of executive stock sales, strategic corporate expansions, and broader market commentary provides a multifaceted view of NVIDIA's current position. While the company demonstrates strong operational momentum and sector influence, the presence of valuation concerns and integration challenges necessitates careful monitoring of both internal developments and external market dynamics.

Risks

  • Potential AI market valuation bubbles as highlighted by investor commentary, which could impact technology sector stability.
  • Integration risks associated with NVIDIA's aggressive acquisition strategy and expansion into new AI and robotics markets.

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026